Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
EYEZ INC, Ordinary Profit/Loss Unexpectedly Turn to Loss for Last Fiscal Year, Returning to Profitability This Year
5242 EYEZ,INC. 【J-GAAP】
Earnings ReportEYEZ,INC. <5242> [TSE Growth] announced its financial results after the market closed on February 13th (15:30). The ordinary profit/loss (non-consolidated) for the fiscal year ended December 2025 turned into a loss of 50 million yen (compared to a profit of 38 million yen in the previous period), falling below the forecast of a 39 million yen, and turning into a loss. For the fiscal year ending December 2026, the ordinary profit/loss is expected to recover to profit of 5 million yen.
In the most recent three-month period, from October to December (4Q), the ordinary profit/loss turned to a loss of 7 million yen (compared to a profit of 15 million yen in the same period last year). The operating profit/loss margin drastically worsened from 5.6% in the same period last year to -4.8%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 1,019 | 39 | 42 | 27 | 27.0 | 0 | Feb 14, 2024 | J-GAAP |
| Dec, 2024 | 1,036 | 32 | 38 | 27 | 26.6 | 0 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 | 965 | -51 | -50 | -68 | -66.6 | 0 | Feb 13, 2026 | J-GAAP |
| YoY | -6.9% | - | - | - | - |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2025 Guidance | 1,049 | 38 | 39 | 27 | 26.3 | 0 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 Results | 965 | -51 | -50 | -68 | -66.6 | 0 | Feb 13, 2026 | J-GAAP |
| Revision Rate | -8.0% | - | - | - | - |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 | 507 | -2 | -2 | -2 | -2.5 | 0 | Aug 14, 2025 | J-GAAP |
| Jan - Jun, 2026 Guidance | ー | ー | ー | ー | - | 0 | Feb 13, 2026 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2024 | 1,036 | 32 | 38 | 27 | 26.6 | 0 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 | 965 | -51 | -50 | -68 | -66.6 | 0 | Feb 13, 2026 | J-GAAP |
| Dec, 2026 Guidance | 1,008 | 7 | 5 | 3 | 2.9 | 0 | Feb 13, 2026 | J-GAAP |
| YoY | +4.5% | - | - | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 248 | 14 | 15 | 12 | 11.8 | 5.6 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 248 | -3 | -2 | -2 | -2.4 | -1.2 | May 15, 2025 | J-GAAP |
| Apr - Jun, 2025 | 259 | 1 | 0 | 0 | -0.1 | 0.4 | Aug 14, 2025 | J-GAAP |
| Jul - Sep, 2025 | 210 | -37 | -41 | -39 | -38.3 | -17.6 | Nov 14, 2025 | J-GAAP |
| Oct - Dec, 2025 | 248 | -12 | -7 | -27 | -26.4 | -4.8 | Feb 13, 2026 | J-GAAP |
| YoY | 0.0% | - | - | - | - |
Related Articles
Nxera Pharma, Last Fiscal Year's Net Income Loss Widens, Current period performance is undisclosed.
MEEQ, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 63%, Oct-Dec Ordinary Profit Increases by 2.1 times
Thinca, The Current Fiscal Year's Net Income Turns to Loss
OPTORUN, 2.3 times Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 Yen
NOVARESE, 89% Increase in Net Income for the Last Fiscal Year, Current period performance is undisclosed.
WILSON LEARNING WORLDWIDE, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Narrows, Oct-Dec Ordinary Profit Loss Narrows
Excite Holdings, Apr-Dec (Cumulative 3Q) Net Income Decreases by 92%
Appier Group, 35% Increase in Net Income, Record High for The First Time in Two Years, Dividend Raised by 0.05 Yen
SOLIZE , Last Fiscal Year's Ordinary Profit Exceeds Expectations, 6.1 times Increase in The Current Fiscal Year
FRIENDLY, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens